Nefopam Misuse: A Cross‐Sectional Study in France
This work is a snapshot of nefopam usage in France. It sheds light on contraindicated uses (in subjects under 15 years of age or with epilepsy), not recommended uses (chronic usage, or in the elderly) and reports the usage of this treatment in the most deprived patients. This article cautions against underestimating the dangers and pitfalls of this treatment, especially in light of mounting evidence of pharmacodependence.
Authors
- Julien Grosjean (ORCID: https://orcid.org/0000-0002-7446-644X)
- E. Lacroix
- R. Varin (ORCID: https://orcid.org/0000-0002-8871-9102)
- André Gillibert (ORCID: https://orcid.org/0000-0002-0797-1817)
- Sophie Pouplin (ORCID: https://orcid.org/0000-0002-5797-4813)
- Pauline Brevet (ORCID: https://orcid.org/0000-0002-5398-0722)
- Bénédicte Gérard
- Éric Barat (ORCID: https://orcid.org/0000-0001-5300-6244)
- R. Léguillon
Institutions
- Inserm (FR)
- Université Sorbonne Nouvelle (FR)
- Sorbonne Université (FR)
- Normandie Université (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
- Département d'Informatique (FR)
- Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé
- Université de Rouen Normandie (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- European Journal of Pain
- Published
- 2025-07-20
- DOI
- https://doi.org/10.1002/ejp.70083
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47